Artificial Intelligence

Imagine Pediatrics wins a top award for its 24/7 care model, proving value-based care can transform lives for children with special needs and save millions.

A new report reveals sophisticated 'cloaking' is the top reason for ad account bans, highlighting a multi-billion dollar shadow war in online advertising.

Forrester's latest report crowns Temenos a leader, highlighting its advanced architecture as a key strategy for banks in the competitive, AI-driven era.

A new AI tool from auction app Tilt automates product listings in seconds, promising to slash seller admin and redefine efficiency in the live shopping market.

A new partnership between a top Asian film festival and the Japan Africa Entertainment Business Council aims to unlock Africa's $52B market for creators.

As Icahn Enterprises preps its May 6 earnings call, investors will weigh mixed industry outlooks, past performance, and its unique MLP structure.

Ascidian Therapeutics to present first human safety data for its Stargardt disease drug, a new RNA editing technology with broad potential for genetic diseases.

Florida's only GitHub Copilot Dev Days, sponsored by NLP Logix, brings industry giants to Jacksonville to explore the future of AI-assisted development.

South Korean AI firm HoneyNaps brings its FDA-cleared sleep diagnostic tech to Boston's biotech hub, aiming to disrupt the multi-billion dollar market.

A new collaboration aims to merge drugs with AI-driven apps, creating a novel class of therapy that could revolutionize treatment, starting with rare cancers.

With 2030 elimination goals at risk, a new partnership combines a proven community model with global data to accelerate the fight against hepatitis B.

Zurich launches a major AI-focused capability center in Hyderabad, signaling a strategic shift to harness Indian tech talent for global insurance innovation.

A new platform aims to solve AI's generic content problem by unifying data from 20+ global platforms, turning standard AI into a personalized business engine.

A new partnership between OpenLegacy and Deloitte Tohmatsu offers a low-risk path for Japanese firms to modernize aging mainframes and avert a looming economic crisis.

Swedish firm pureSignal partners with Icelandic distributor, bringing AI-driven predictive maintenance to the region's key energy and industrial sectors.

The Chinese AI credit platform's latest ESG report signals a growing focus on sustainability and social impact amid tightening market and regulatory pressures.

Biotech firm Tr1X unveils promising data for its novel cell therapies, offering a scalable new approach to treating autoimmune diseases like MS and GvHD.

Encoded Therapeutics is set to unveil pivotal data on ETX101, a one-time gene therapy showing promise in not just stopping seizures but reversing developmental delays.

Dyno Therapeutics is using AI to design 'smart' viral vectors, promising safer, more effective treatments for untreatable genetic diseases.

Biotech firm Cellectis presents a new epigenetic platform that silences genes without cutting DNA, a potentially safer approach for cancer and liver disease.